|
National Stock Number(NSN): 6505-00-147-8347 (6505001478347, 001478347)
| NIIN: |
00-147-8347 |
Item Name: |
CODEINE PHOSPHATE AND ACETAMINOPHEN TABLETS |
INC: |
33357
|
| FSC: |
6505
|
Assignment Date: |
Sep-29-1971 |
CRIT: |
N |
IIG: |
33357 |
| ISC: |
2 |
Date Standardized: |
Nov-06-1978 |
HMIC: |
Y |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Jun-01-2001 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
A-A-30033 |
58536
|
FEDERAL COMMERCIAL ITEM DESCRIPTION PROMULGATED BY GENERAL SERVICES ADMINISTRATION WASHINGTON DC |
H |
5 |
9 |
3 |
54 |
|
|
|
|
|
|
|
NDC00045-0513-70 |
04501
|
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV |
H |
3 |
2 |
4 |
54 |
|
|
|
|
|
|
|
NDC00536-3227-05 |
4V824
|
RUGBY GROUP INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
TYLEN0LWITHC0DE1NEN03 |
04501
|
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV |
H |
3 |
1 |
6 |
75 |
3 |
D |
|
|
|
|
|
TYLENOL WITH CODEINE TABLETS |
04501
|
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV |
H |
5 |
1 |
4 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
Q |
Q |
1 |
A |
$24.89 |
BT |
|
C2201X- |
May-01-1997 |
H |
| DF |
JDC |
L |
|
Q |
Q |
1 |
F |
$24.89 |
BT |
|
------- |
Feb-01-1997 |
H |
| DM |
JDC |
L |
Z |
Q |
Q |
1 |
M |
$24.89 |
BT |
|
1354--1 |
Feb-01-1997 |
H |
| DN |
JDC |
L |
|
Q |
Q |
1 |
N |
$24.89 |
BT |
|
9L----- |
Feb-01-1997 |
H |
| DS |
JDC |
L |
|
Q |
Q |
1 |
D |
$24.89 |
BT |
|
------- |
Feb-01-1997 |
H |
| GP |
JDC |
L |
|
Q |
Q |
1 |
C |
$24.89 |
BT |
|
------- |
Feb-01-1997 |
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
30.000 MILLIGRAMS CODEINE PHOSPHATE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
500.000 TABLETS |
| CSGS |
ADMINISTRATION |
ORAL |
| CTSF |
PROTECTIVE STORAGE FEATURE |
EXPIRATION DATED AND SECURITY STORAGE |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
40.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
1.20 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
48 |
| FEAT |
SPECIAL FEATURES |
THE ACTIVE INGEDIENT ACETAMINOPHEN CAN BE EITHER 300.000 OR 325.000 MG; NONCHEWABLE |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
12 |
| SUCB |
UNIT OF ISSUE CUBE |
0.025 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.83 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Feb-26-1996 |
3 |
Z |
|
|
|
|
| C009 |
|
Feb-26-1996 |
3 |
Z |
|
|
|
|
| FSKX |
|
Feb-26-1996 |
3 |
Z |
|
|
|
|
| MC15 |
|
Feb-26-1996 |
3 |
Z |
|
|
|
|
| N9LM |
|
Feb-26-1996 |
3 |
Z |
|
|
|
|
| YK01 |
|
Apr-01-1991 |
|
|
|
|
YK |
YK |
Replacement & Obsolete Information
| Obsolete NIIN Information |
|